Introduction of a reactive 5-mercapto group into some of the cytosine and/or uracil bases of various oligoand polynucleotides by partial thiolation resulted in several potent inhibitors of the replication of human immunodeficiency virus type 1 (HIV-1) in primary human lymphocytes. These compounds exhibited little if any toxicity against uninfected peripheral blood mononuclear cells and showed 15 to 75 times higher antitemplate activity against a p66/p5i HIV-1 recombinant reverse transcriptase (RT) than against the DNA polymerase a from human lymphocytes. In contrast, the unthiolated oligo-and polynucleotides are void of antitemplate activity, and their apparent inhibitory effect on HIV-1 closely paralleled their toxicity for the cells. Partially thiolated poly(dC) (MPdC) was the most potent of all the compounds tested against HIV-1 in peripheral blood mononuclear cells (50% effective concentration, 1.8 ,ug/ml or 0.019 ,uM), while showing low cytotoxicity (>100 ,ug/ml). The corresponding unmodified poly(dC) showed no anti-HIV-1 activity at 50 ,ug/ml but had pronounced cytotoxicity. MPdC was also a potent inhibitor of HIV-1 RT (50% inhibitory concentration, 0.30 ,ug/ml). The inhibitory activities of thiolated homooligo(dCs) against both HIV-1 replication and HIV-1 RT increased with increasing chain length. The heterooligonucleotides included in this study were designed as structural analogs of portions of the natural primer of HIV-1 RT, i.e., tRNArYs. An 18-mer analog of the 3' terminus, complementary (antisense) to the primer-binding site of the HIV-1 genome, was attached to an oligo(dC) tail and 5-thiolated; this increased its activity and decreased its toxicity. This compound will serve as a new lead in the development of more effective antitemplates against HIV-1.
Previous reports from this laboratory described the preparation and properties of a new type of enzyme inhibitors, termed antitemplates (4) , which were obtained by the introduction of a reactive 5-mercapto group into some of the cytosine and/or uracil bases of synthetic or natural RNA and DNA molecules (7, 8, 22, 24, 34) . These partially thiolated polynucleotides were found to inhibit various RNA and DNA polymerases by effectively competing with the functional templates or primers for their binding sites on the enzymes and thus blocking their functions (6, 29) . In particular, the reverse transcriptases (RTs) of RNA tumor viruses (11, 12, 30) , the herpes simplex virus-induced DNA polymerase (10) , and the DNA polymerase a of mammalian cells (29, 32) were found to be sensitive to inhibition by 5-thiolated polynucleotide antitemplates. The magnitude of the inhibitory effect and the K/Km ratio (29) depends on the nature and base composition of both the antitemplate and the template primer used (30) , as well as on the purity of the enzyme and its sensitivity toward thiol reagents (32) . It was further found that 5-thiolated polynucleotides (particularly DNAs) are more resistant than their unmodified counterparts to degradation by nucleases (8) and are readily taken up both in vitro by tumor cells (35) and in vivo by the bone marrow and spleen of leukemic mice (24, 31) . Most of these studies have been conducted either with partially thiolated natural DNAs (or RNAs) or with 5-mercapto-substituted poly(C) and poly(U), designated as MPC and MPU, respec-* Corresponding author.
tively. 5-Thiolated oligocytidylates were less active than MPC, and their inhibitory activity against DNA and RNA polymerases increased with increasing chain length (23) .
More recently, Chandra et al. (13) reported that MPC and MPU inhibited the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1). Furthermore, in collaboration with our laboratory, Aradi et al. (2) reported that MPC and MPU, as well as the double-stranded complex of MPU with poly(A), inhibited the replication and cytopathic effect of HIV-1 in cultured H9 human lymphocytes; an enzymatically prepared MPU was the most active among those tested. In the present paper, we report a comparative study of a variety of 5-thiolated oligo-and polynucleotides of different chain lengths and base composition, as well as their unmodified counterparts, with respect to (i) antiviral activity against HIV-1 in primary human peripheral blood mononuclear cells (PBMC); (ii) toxicity to uninfected PBMC by using a tritiated-thymidine uptake method; and (iii) inhibitory activities against recombinant HIV-1 RT, as well as against a highly purified DNA polymerase a from human lymphocytes in cell-free systems. The aim of the present study was to explore the general scope and rules of the activities and selectivities of 5-mercapto-substituted oligoand polynucleotides as a new class of inhibitors of the replication of HIV-1 and to gain some insight into their mode of action.
( (27) was prepared by published procedures. Briefly, treatment of 2,2'-anhydrouridine with HCl gas yielded 2'-chlorodeoxyuridine (18) , which was phosphorylated by the method reported by Yoshikawa et al. (43) and then converted via the N,Ncarbonyldiimidazole derivative into the desired diphosphate by using tri-n-butylammonium Pi (26) . The diphosphate was subsequently polymerized, by using the polynucleotide phosphorylase of Micrococcus luteus (Sigma Chemical Co., St. Louis, Mo.) and the method previously developed in this laboratory (21) . The lack of 2'-hydroxyl groups was confirmed by the stability of the chlorinated polymer to hydrolysis upon treatment with RNase A. Thus, treatment of 0.5 mg of RNA substrate in 2 ml of 0. (4 mg/ml). In either case, the sodium salt of the thiolated product was collected by centrifugation, washed three times with methanol or acetone to remove the cetyltrimethylammonium chloride or iodide, and then allowed to dry by exposure to air for 10 min. It was then dissolved in 10 mM Tris-HCl buffer (pH 7.4) and purified by the appropriate size exclusion chromatography to give an approximately 60% yield-of the partially thiolated oligo-or polynucleotide, which appeared to be homogeneous (by polyacrylamide gel electrophoresis, as above). The percent thiolation (percentage of 5-mercaptopyrimidines per total bases) was determined by measuring the difference in the A334 in the presence and absence of dithiothreitol and using a semiempirical equation as described previously (22) . The accuracy of this determination is ±5% of the mean value. The calculated numbers of 5-thiol groups per molecule were rounded to the closest whole numbers.
Antiviral and cytotoxicity methods. The antiviral assays were conducted in mitogen-stimulated human PBMC infected with HIV-1 (strain LAV), as described previously (37) . The virus concentration used for infection was about 63,000 dpm of RT activity per 107 cells per 10 ml of medium. The drugs were added about 45 min after infection. The cultures were maintained in a humidified 5% C02-95% air incubator at 37°C for 6 days after infection, at which point all cultures were sampled for supernatant RT activity. Previous studies by Schinazi and coworkers had indicated that maximum RT levels were obtained at that time (16, 17, 33, 39) . The supernatant was clarified, and the virus particles were pelleted at 100,000 x g for 30 min by using a 70.1 Ti rotor (Beckman Instruments, Fullerton, Calif.) and suspended in virus-disrupting buffer. The RT assay was performed in 96-well microdilution plates with poly(rA)" * (dT)12_18 as the template-primer (37). 3'-Azido-3'-deoxythymidine was included in every assay as a positive control and consistently showed 50% effective concentrations (EC50) values of 0.002 to 0.006 p,M.
The drugs were also evaluated for their potential toxic effects on uninfected phytohemagglutinin-stimulated human PBMC by using a radioactive thymidine uptake method. Briefly, cells in a 96-well plate were grown in the presence of drug for 24 h, and then 1 ,uCi of [3H]thymidine (specific activity, 69 Ci/mmol) was added to each well. After 24 h, the cells were harvested on glass fibers, washed, and dried, and the amount of radioactivity associated with the cells was determined. Cycloheximide was included as a control for toxicity in every assay.
Data analysis. The EC50 for HIV-1 and 50% inhibitory concentrations (IC50) for PBMC were derived from the computer-generated median effect plot of the dose-effect data, as described previously (14, 15) . Each value is the mean of two or three separate determinations. Variation between assays with different blood donors was less than 10%.
Effect of compounds in cell-free systems. (i) HIV-1 RT. A recombinant p66/pSi HIV-1 RT was obtained from Biotechnology General and used for all of the HIV-1 RT assays reported in this paper. The specific activity of the enzyme was 5,600 U/mg of protein (where 1 U of enzyme is defined as the amount required to incorporate 1 nmol of [32P]dTTP, following 10 min of polymerization, per mg of protein). The assays were performed as described previously by Schinazi VOL. 36, 1992 on October 28, 2017 by guest http://aac.asm.org/ Downloaded from was carried out for 60 min at 37°C and was followed by workup as described above for the RT assay.
(iii) Data analysis. In all enzyme assays, duplicate samples were run and the average counts per minute were calculated; control values were taken as an average of two samples without drug. IC50s for both the HIV-1 RT and DNA polymerase a assays were calculated from the computergenerated median effect plot of the dose-response data. Each of the values is the mean of two or three separate experiments, in several cases involving different preparations of the same compound; the variance was ±4% from the mean value.
RESULTS
The compounds discussed in the present paper are conveniently grouped into three categories: homopolynucleotides (see Table 1 ); homooligonucleotides (see Table 2 ); and sequence-specific heterooligonucleotides (see Table 3 ). Each 5-thiolated compound (indicated by M preceding the composition symbol) was directly compared with the corresponding unmodified oligo-or polynucleotide from which it was derived. In the composition symbols, dCn stands for an oligonucleotide consisting of n 2'-deoxycytidylate units. The cell-free RT assays were performed with both templateprimers, but the -results obtained with poly(rC), (dG) are given only when they are different from those obtained with poly(rA),, (dT)12_18.
Polynucleotides. Among the homopolynucleotides (Table  1 ) and, indeed, among all the compounds tested, the thiolated poly(dC) (MPdC) was by far the most active against HIV-1, in terms of both micrograms per milliliter and molar concentration (EC50 = 1.8 ,ug/ml or 0.019 ,uM). MPdC was also a potent inhibitor of the cell-free (recombinant) HIV-1 RT. At the same time, it showed relatively low cytotoxicity against the uninfected PBMC (IC50 > 100 ,ug/ml). In contrast, its unthiolated counterpart, poly(dC), showed no anti-HIV-1 activity but showed pronounced cytotoxicity at 44 ,ug/ml.
In comparison with MPdC, the thiolated polyribonucleotides tested exhibited by more than an order of magnitude lower activities against HIV-1, with MPU being more active than MPC. The unthiolated polyribonucleotides poly(U) and poly(C) showed neither antiviral activity nor cytotoxicity. In the cell-free HIV-1 RT assay, MPU and poly(U) showed extraordinarily high inhibitory activities. MPU was 1,000 times more active against the cell-free enzyme than against HIV-1 in the infected cells, compared with a mere sixfold difference between the relative activities of MPdC in the same test systems. To determine whether this anomaly was due to direct interaction of the uridylate sequences present in both MPU and poly(U) with the "artificial" templateprimer, poly(rA) * (dT)12_18 used in the enzyme assay, these compounds were also tested with poly(rC) * (dG)12_.8 as the template-primer and [3H]dGTP as the labeled substrate. However, the inhibitory activity of MPU against HIV-1 RT remained the same, whereas that of poly(U) decreased by 3 orders of magnitude under the latter conditions. The template-depen'dent inhibition of other RTs by poly(U) has been reported (30, 41) . The 2'-chloro-2'-deoxy analog of MPU, MPCldU, showed the same activities as MPU against both the cell-free enzyme and the virus assay. Replacement of all 2'-OH groups with the isosteric chlorine greatly increa'sed the stability of MPU toward hydrolysis by nucleases, as expected (see Materials and Methods), but this did not result in any increase of its activity against Homooligonucleotides. Among the homooligonucleotides (Table 2) , the thiolated oligodeoxynucleotides exhibited increasing inhibitory activities with increasing chain length against both HIV-1 and cell-free HIV-1 RT and, at the same tine, generally decreasing toxicities against the uninfected PBMC. The thiolated 40-mer, M(dC40), was, on a microgram-per-milliliter basis, nearly as active (and relatively nontoxic) as MPdC in all the assays. For the series of three oligo(dC)s and poly(dC)s, M(dC25), M(dC40), and MPdC, the ratio of activities against HIV-1 and against HIV-1 RT was constant (EC50/IC5O = 6.1 ± 0.4).
Comparison of the inhibitory activities against HIV-1 RT with those against the DNA polymerase a derived from human lymphocytes revealed that the IC50 ratios (HIV-1 RT to DNA polymerase a) were 0.05 for MPdC (Table 1) and 0.07 for M(dC40) ( Table 2 ), corresponding to 20-and 15-fold selectivity, respectively, against the viral enzyme.
The corresponding unmodified homooligodeoxynucleotides also exhibited some definite antiviral activities, which, however, were consistently lower than those of their thiolated counterparts and, in contrast to the latter, eventually decreased (rather than increased) with increasing chain length. Moreover, these unmodified oligomers, particularly those of fewer than 40 nucleotides (e.g., dC28), were highly toxic to the cells; in fact, their toxicities closely paralleled their antiviral activities. In addition, they did not show any significant inhibitory activity against the cell-free enzyme; they even stimulated it when poly(rC) (dG)1218 was used as the template-primer.
Heterooligonucleotides. The heterooligonucleotides included in the present study (Table 3) were designed to be structural analogs of parts of the natural primer of HIV-1 RT, tRNA'Ys (9) , which, in the 5-thiolated state, is a potent inhibitor of HIV-1 (5). Thus, the hetero-18-mer, 5'-GTC-CCT-GTT-CGG-GCG-CCA-3', designated dN18t, is a 2'-deoxy analog of the 3'-terminus of tRNA'YS, and it is complementary (antisense) to the primer-binding site of the HIV genome. Thymidine was placed in positions where uridine was located in the natural ribonucleotide sequence for the sake of synthetic expediency. The dN18t showed moderate anti-HIV-1 activity, but also exhibited significant cytotoxicity. Its partially thiolated counterpart, M(dN18t), which at the maximum attainable (4 to 5%) thiolation contained only one 5-mercapto group per molecule, was slightly more active and less toxic. No attempt was made to separate the 10 to 15% unmodified molecules present in the preparation. Attachment of an oligo-dC22 tail to its 5' end permitted satisfactory thiolation to give the composite 40-mer, M(dC22-dN18t), which was significantly more active against HIV-1 than was either M(dN18t) or M(dC25) [the latter being the closest homolog of M(dC22) tested], particularly on a molar basis (EC50 = 0.65 ,uM versus 2.0 and 1.7 ,uM, respectively) and, in contrast to both, showed no cytotoxicity. Attachment of the shorter M(dC14) tail was less effective.
The other heterooligonucleotide included in Table 3 , the 17-mer 5'-CAG-ACT-TTT-AAT-CTG-AG-3', designated as dN17ac, is an analog of the unprocessed anticodon loop of tRNA YS that may have a role in the binding of the primer to the HIV-1 RT (9) . Again, the uridine moieties of the anticodon loop were replaced with thymidine and the modified bases 2-methylthio-N6-threonyl-adenosine (A*) and 2-thio-5-carboxymethyl-uridine methyl ester (U*) were replaced with the corresponding unmodified A and T, respectively. With only three cytosine bases in the molecule, dN17ac resisted complete 5-thiolation. After attachment of an oligo(dC23) tail to its 3' end, it was readily thiolated to give the composite 40-mer M(dN17ac-dC23), which showed high activity against both HIV-1 and HIV-1 RT, similar to that of M(dC22-dN18t), but had much higher cytotoxicity. Its unthiolated counterpart, dN17ac-dC23, was considerably less active against VOL. 36, 1992 on October 28, 2017 by guest http://aac.asm.org/ Downloaded from [29] ) showed uncompetitive kinetics (10); conversely, it could be expected to have relatively little effect on HIV-1 in the cell culture system.
The inhibitory activities of 5-thiolated oligo(dCs) against both HIV-1 and HIV-1 RT increased with increasing chain length and, at the 40-mer level, approached (on a weight basis) the activities of the corresponding polynucleotide, MPdC. The excellent correlation between the activities in the cell culture and cell-free HIV-1 assay systems (EC50IC50 = constant) suggests that the antiviral activities of 5-thiolated oligo(dC)s and poly(dC)s are due to their antitemplate effects on the viral RT in the infected cells.
In contrast, the apparent anti-HIV-1 activities of the unmodified homooligonucleotides (previously noted by Agrawal et al. [1] ) are not accompanied by any significant inhibitory activity against the HIV-1 RT and are therefore not due to the antitemplate effect. Instead, they closely parallel the toxicities of these compounds toward PBMC (even as they decrease with increasing chain length), suggesting that their apparent antiviral activity is actually due to their toxicity to the host cells.
The apparently promising combination of a thiolated homooligodeoxynucleotide, M(dC22), with a heterooligodeoxynucleotide, M(dN,8t), having a base sequence complementary or antisense (20, 44, 45) to the primer-binding site of the viral genome may represent an interesting lead for the design of more effective antitemplates. The higher anti-HIV-1 activity of this construct than those of its two components, and especially its lower toxicity and its higher degree of selectivity toward the HIV-1 RT compared with the DNA polymerase a of the host cells, may be due to sequence-specific targeting or even to reinforced binding to both the viral RNA as well as the RT, with the resulting more efficient displacement of the tRNA primer from the transcription initiation complex.
In view of the generally favorable effects of the introduction of one or more 5-mercapto groups per molecule on the antiviral activity, cytotoxicity, stability to nucleases (8) , and cellular uptake (35) , at the expense of only slightly reduced hybridization potential, it appears feasible to use 5-thiolation (or 5-mercapto-2'-deoxynucleotide incorporation via stepwise synthesis) instead of backbone modification in the design of antisense oligonucleotides as well as of antitemplates. This approach would avoid the chirality problem (42) resulting from modification of the internucleotide phosphate groups.
